EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Redox-Sensitive Delivery of Doxorubicin from Nanoparticles of Poly(ethylene glycol)-Chitosan Copolymer for Treatment of Drug-Resistant Oral Cancer Cells

Kaengwon Yoon, Seunggon Jung, Jaeyoung Ryu iD, Hong-Ju Park, Hee-Kyun Oh, Min-Suk Kook iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241813704 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Kaengwon Yoon und 5 weiteren Autor:innen. Beteiligte Einrichtung: El-Dental Clinic, Seomun Daero Street 625, Namgu, Gwangju 61737, Republic of Korea. Hauptthemen laut MEDLINE: Doxorubicin, Chitosan, Polyethylene Glycols, Nanoparticles. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chonnam National University Hospital Biomedical Research Institute, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reactive oxygen species (ROS)-sensitive polymer nanoparticles were synthesized for tumor targeting of an anticancer drug, doxorubicin (DOX). For this purpose, chitosan-methoxy poly(ethylene glycol) (mPEG) (ChitoPEG)-graft copolymer was synthesized and then DOX was conjugated to the backbone of chitosan using a thioketal linker. Subsequently, the chemical structure of the DOX-conjugated ChitoPEG copolymer (ChitoPEGthDOX) was confirmed via 1H nuclear magnetic resonance (NMR) spectra. Nanoparticles of the ChitoPEGthDOX conjugates have spherical shapes and a size of approximately 100 nm. Transmission electron microscopy (TEM) has shown that ChitoPEGthDOX nanoparticles disintegrate in the presence of hydrogen peroxide and the particle size distribution also changes from a monomodal/narrow distribution pattern to a multi-modal/wide distribution pattern. Furthermore, DOX is released faster in the presence of hydrogen peroxide. These results indicated that ChitoPEGthDOX nanoparticles have ROS sensitivity. The anticancer activity of the nanoparticles was evaluated using AT84 oral squamous carcinoma cells. Moreover, DOX-resistant AT84 cells were prepared in vitro. DOX and its nanoparticles showed dose-dependent cytotoxicity in both DOX-sensitive and DOX-resistant AT84 cells in vitro. However, DOX itself showed reduced cytotoxicity against DOX-resistant AT84 cells, while the nanoparticles showed almost similar cytotoxicity to DOX-sensitive and DOX-resistant AT84 cells. This result may be due to the inhibition of intracellular delivery of free DOX, while nanoparticles were efficiently internalized in DOX-resistant cells. The in vivo study of a DOX-resistant AT84 cell-bearing tumor xenograft model showed that nanoparticles have higher antitumor efficacy than those found in free DOX treatment. These results may be related to the efficient accumulation of nanoparticles in the tumor tissue, i.e., the fluorescence intensity in the tumor tissue was stronger than that of any other organs. Our findings suggest that ChitoPEGthDOX nanoparticles may be a promising candidate for ROS-sensitive anticancer delivery against DOX-resistant oral cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinChitosanPolyethylene GlycolsNanoparticlesMouth NeoplasmsDrug Resistance, NeoplasmHumansAnimalsCell Line, TumorOxidation-ReductionMiceReactive Oxygen SpeciesDrug CarriersDrug Delivery SystemsAntibiotics, Antineoplastic

Stichwörter der Autor:innen

ROS-sensitive drug deliverydoxorubicindrug-resistantnanoparticlesoral squamous carcinoma cells

Substanzen

DoxorubicinChitosanPolyethylene GlycolsReactive Oxygen SpeciesDrug CarriersAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • El-Dental Clinic, Seomun Daero Street 625, Namgu, Gwangju 61737, Republic of Korea.
  • Department of Maxillofacial Oral Surgery, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of Korea.

ORCID-Profile: Jaeyoung Ryu, Min-Suk Kook

Förderung

  • Chonnam National University Hospital Biomedical Research Institute, Republic of Korea

Zitieren

APA

Yoon, K., Jung, S., Ryu, J., Park, H. J., Oh, H. K., & Kook, M. S. (2023). Redox-Sensitive Delivery of Doxorubicin from Nanoparticles of Poly(ethylene glycol)-Chitosan Copolymer for Treatment of Drug-Resistant Oral Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241813704

Vancouver

Yoon K, Jung S, Ryu J, Park HJ, Oh HK, Kook MS. Redox-Sensitive Delivery of Doxorubicin from Nanoparticles of Poly(ethylene glycol)-Chitosan Copolymer for Treatment of Drug-Resistant Oral Cancer Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241813704

BibTeX
@article{Yoon2023,
  author = {Yoon, Kaengwon and Jung, Seunggon and Ryu, Jaeyoung and Park, Hong-Ju and Oh, Hee-Kyun and Kook, Min-Suk},
  title = {Redox-Sensitive Delivery of Doxorubicin from Nanoparticles of Poly(ethylene glycol)-Chitosan Copolymer for Treatment of Drug-Resistant Oral Cancer Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241813704}
}
Kostenlos starten →